Skip to main content
Table of Contents
Print

How long do I need to stay on dual antiplatelet therapy after a stent?Ā 

Author: Harry Whitmore, Medical Student | Reviewed by: Dr. Rebecca Fernandez, MBBS

Receiving a stent is a life-saving procedure, but the metal strut itself poses a temporary risk: until your body’s natural tissue grows over it, the stent is a magnet for blood clots. To prevent this, doctors prescribe ā€˜Dual Antiplatelet Therapy’ (DAPT), a combination of Aspirin plus a second, stronger blood thinner (like Clopidogrel, Ticagrelor, or Prasugrel). The duration of this therapy is not random; it is a calculated decision based on your specific condition and your risk of bleeding. 

What We’ll Discuss in This Article 

  • The Standard Timeline: Why 12 months is the default for most heart attack patients. 
  • Elective vs. Emergency: How the rules differ for stable angina (6 months) vs. heart attacks. 
  • The ā€˜Stent Thrombosis’ Risk: Why stopping too early can be fatal. 
  • High Bleeding Risk: When doctors shorten the course to 3 months or even 1 month. 
  • Drug-Eluting Stents (DES): Why modern stents are safer but still need protection. 
  • The ā€˜Lifer’ Drug: Why aspirin usually continues forever even after DAPT stops. 

The Standard Rules of Thumb 

While every patient is unique, guidelines generally divide patients into two categories: 

For Acute Coronary Syndrome (Heart Attack) 

If you had your stent fitted during an emergency (a heart attack or unstable angina), the standard duration for DAPT is 12 months. 

  • Why: The inflammation and clotting risk in your blood are much higher after a heart attack. You need longer protection to let the artery calm down and the stent to heal fully. 

For Chronic Coronary Syndrome (Stable Angina) 

If you had a planned (elective) stent for stable chest pain, the standard duration is usually 6 months. 

Why not just stay on it forever? 

The Trade-Off: Clotting vs. Bleeding 

You might think, ā€˜Why not take both drugs forever to be safe?’ The answer is bleeding risk. Taking two strong blood thinners significantly increases your risk of internal bleeding (e.g., stomach ulcers, brain bleeds). 

  • The Sweet Spot: Doctors aim to stop the second drug as soon as the risk of the stent clotting (thrombosis) drops below the risk of you having a serious bleed. This crossover point is usually around 6–12 months. 

Exceptions: Shorter or Longer? 

Your cardiologist may deviate from the standard rules based on your ā€˜Bleeding Risk Score’ (often calculated using a tool called PRECISE-DAPT). 

Shortening Therapy (1–3 Months) 

If you are at high risk of bleeding (e.g., elderly, history of ulcers, on blood thinners for AFib, or anaemic), your doctor may stop the second drug after just 3 months, or even 1 month. Modern drug-eluting stents heal faster than older ones, making this safe for high-risk patients. 

Extending Therapy (>12 Months) 

If you are at low bleeding risk but have very high ischaemic risk (e.g., you’ve had multiple heart attacks, have diabetes, or have many stents), your doctor may recommend continuing DAPT for up to 3 years. This is aggressive protection for high-risk arteries. 

What happens when I stop? 

Stopping DAPT does not mean stopping all medication. It usually means stopping the second drug (Clopidogrel/Ticagrelor) while continuing Aspirin for life. 

  • The Drop-Down: You go from two drugs to one. This single drug (Aspirin) provides enough ā€˜non-stick’ protection for the healed stent without the high bleeding risk of dual therapy. 
  • No Rebound: There is generally no ā€˜rebound’ effect if you stop at the correct time (e.g., 12 months). The stent is fully endothelialised (covered in skin cells) by then. 

Conclusion 

The duration of your dual antiplatelet therapy is a personalised prescription, not a fixed rule. For most heart attack survivors, it is 12 months. For stable patients, it is 6 months. However, this can change if you have a bleed or need urgent surgery. The most important rule is never to stop early on your own. Stopping DAPT prematurely is the single biggest cause of stent thrombosis, a sudden, often fatal, blockage of the stent. 

If you notice unexplained bruising, black stools, or nosebleeds that won’t stop, contact your doctor immediately. They may need to adjust your DAPT duration. 

Can I stop early for dental work?Ā 

Usually, no.Ā Most dental work (fillings, extractions) can be done while on DAPT. The risk of stopping the heart medication is far dangerous than the risk of gum bleeding. Always consult your cardiologist.Ā 

What if I miss a dose?Ā 

Take it as soon as you remember. If it isĀ nearly timeĀ for the next dose, skip the missed one. Never double up. Missing a single dose is rarely catastrophic, but missing several days is dangerous.Ā 

Why am I on Ticagrelor instead of Clopidogrel?Ā 

Ticagrelor is a more potent, faster-acting drug often preferred for heart attack patients. Clopidogrel is older and milder, often used for stable patients or those with higher bleeding risks.Ā 

Does the type of stent matter?Ā 

Yes.Ā ModernĀ ā€˜Drug-Eluting Stents’ (DES) require DAPT to prevent clotting while the drug is released.Ā OlderĀ ā€˜Bare Metal Stents’ (rarely used now)Ā requiredĀ shorter durations (1 month) but had higher rates of re-narrowing long-term.Ā 

I have bruising everywhere, should I stop?Ā 

Not without medical advice.Ā ā€˜Nuisance bruising’ is common and not dangerous. However, if the bruising is spontaneous (appearing without injury) orĀ very large, see your doctor to check your blood counts.Ā 

Can I drink alcohol on DAPT?Ā 

In moderation.Ā Alcohol can irritate the stomach lining. Combined with DAPT, this increases the risk of a stomach bleed. Stick to recommended limits.Ā 

What isĀ ā€˜Triple Therapy’?Ā 

If you have Atrial Fibrillation (AFib) and a stent, you might need an anticoagulant (blood thinner) PLUS two antiplatelets. This isĀ very highĀ risk for bleeding and is usually only kept up forĀ a very shortĀ time (e.g., 1 week to 1 month) before dropping one antiplatelet.Ā 

Authority Snapshot 

This article was written by Dr. Stefan Petrov, a UK-trained physician (MBBS) with extensive experience in acute cardiac care and post-procedure management. Having discharged countless patients following angioplasty, Dr. Petrov explains the delicate balancing act between preventing stent clots and managing bleeding risk. This content has been reviewed to ensure strict alignment with NHS and European Society of Cardiology (ESC) guidelines. 

Harry Whitmore, Medical Student
Author
Dr. Rebecca Fernandez, MBBS
Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy.Ā 

Categories